Search research articles
Contact Us
Filters
Showing results (281-290 of 289) with videos related to
Page
of 29
Sort By:
You have reached the last page of results.
This site can display upto 289 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
C Manegold, N van Zandwijk, A Szczesna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 3, 2013
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer
T Ciuleanu, C-M Tsai, C-J Tsao, et al.
British Journal of Cancer
|
November 20, 1998
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
M R Middleton, J M Lunn, C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients
U Keilholz, C Conradt, S S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
M R Middleton, J J Grob, N Aaronson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2011
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer
E F Smit, M A Socinski, B P Mullaney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer
T Brodowicz, T Ciuleanu, J Crawford, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer
P D Bonomi, D Gandara, F R Hirsch, et al.
Page
of 29
Search research articles
Search
Showing results (281-290 of 289) with videos related to
Sort By:
Page
of 29
You have reached the last page of results.
This site can display upto 289 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
C Manegold, N van Zandwijk, A Szczesna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 3, 2013
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer
T Ciuleanu, C-M Tsai, C-J Tsao, et al.
British Journal of Cancer
|
November 20, 1998
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
M R Middleton, J M Lunn, C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients
U Keilholz, C Conradt, S S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
M R Middleton, J J Grob, N Aaronson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2011
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer
E F Smit, M A Socinski, B P Mullaney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer
T Brodowicz, T Ciuleanu, J Crawford, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer
P D Bonomi, D Gandara, F R Hirsch, et al.
Page
of 29